*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Announcement on Special Risk Alerts
*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)
*ST Jingfeng: Progress announcement on pre-restructuring matters
*ST Jingfeng: Announcement on Abnormal Fluctuations and Serious Abnormal Fluctuations in Stock Trading
*ST Jingfeng: Announcement on changes in the company\'s directors and senior management
*ST Jingfeng: 2024 Semi-Annual Financial Report
*ST Jingfeng: 2024 Semi-Annual Report Summary
*ST Jingfeng: Independent Director Nominee\'s Statement and Commitment
*ST Jingfeng: 2024 Semi-Annual Report
*ST Jingfeng: Semi-annual summary of non-operating capital expenditure and other related capital transactions
*ST Jingfeng: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
*ST Jingfeng: Semi-Annual Report Board Resolution Announcement
*ST Jingfeng: Independent Director Candidate Statement and Commitment
*ST Jingfeng: Announcement on Determining Pre-Restructuring Investors and Risk Alerts
*ST Jingfeng: Announcement on Abnormal Fluctuations in Stock Trading
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
Hunan Jingfeng Pharmaceutical: Announcement regarding abnormal fluctuations in stock trading.
No Data
No Data